Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Strong Recent Returns And Oncology Pipeline Focus [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
What recent returns say about Jazz Pharmaceuticals stock Jazz Pharmaceuticals (JAZZ) has drawn investor attention after a strong run, with the share price at $197.83 and total returns of 9% over the past month and 16.8% over the past 3 months. See our latest analysis for Jazz Pharmaceuticals. While the share price pulled back slightly over the last session, it has still delivered a 9.1% 1 month share price return and a 16.8% 3 month share price return, alongside a 92.5% 1 year total shareholder return that points to strong recent momentum. If Jazz Pharmaceuticals has you looking closer at healthcare names, it can be useful to see what else is moving in the sector through 35 healthcare AI stocks With JAZZ trading at $197.83, a value score of 5, an intrinsic value estimate implying a 74.5% discount, and a 13.1% gap to analyst targets, is there still a buying opportunity here or is the market already pricing in future growth? Most Popular Narrative: 9.8% Undervalued The mo
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals Touts Record $4.3B 2025 Revenue, Reaffirms 2026 Outlook at Conference [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals plc (JAZZ) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Jazz Pharmaceuticals (JAZZ) was upgraded by Raymond James Financial, Inc. to "moderate buy".MarketBeat
- Jazz Pharmaceuticals (JAZZ) was given a new $227.00 price target by Raymond James Financial, Inc..MarketBeat
- Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual MeetingPR Newswire
JAZZ
Earnings
- 2/24/26 - Beat
JAZZ
Sec Filings
- 4/3/26 - Form 4
- 4/1/26 - Form 144
- 3/27/26 - Form SCHEDULE
- JAZZ's page on the SEC website